Genomic analysis of BCG unresponsive non-muscle-invasive bladder cancer identifies drivers of sensitivity to intravesical Gemcitabine/Docetaxel
Kendrick H. Yim, Matías Vergara, Jihyun Lee, Brendan Michael Reardon, J Park, Kevin Richard Melnick, Timothy N. Clinton, Matthew Mossanen, Graeme S. Steele, Jessica Bolduc, Michelle S. Hirsch, Natalie M. Rizzo, Chin‐Lee Wu, Matthew F. Wszolek, Keyan Salari, , Filipe L.F. Carvalho
The paper identifies genomic features associated with response or resistance to Gem/Doce in BCG-unresponsive NMIBC using whole-exome sequencing and phylogenetic analysis.
bioRxiv · May 18, 2026 · PreprintGenomics